Trial NCT01995058

View at ClinicalTrials.gov 
Org. Study IDs: XL184-210

Last trial update was posted on 2015-02-20

MeSH Interventions

Abiraterone Acetate Prednisone

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Castration Resistant Prostate Cancer Prostate Cancer

Stopping Reasons

Study stopped after results of cabozantinib Phase 3 CRPC study XL184-307.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID